Search research articles
Contact Us
Filters
Showing results (411-420 of 467) with videos related to
Page
of 47
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2025
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC)
Elise Pesonel, Cédric Laouénan, Laetitia Guiraud, et al.
Eclinicalmedicine
|
January 22, 2026
Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations
Win Min Han, Bastian Neesgaard, Michael Knappik, et al.
Lancet (London, England)
|
July 20, 2010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
, Rebecca K Lodwick, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 8, 2024
Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium
Dhanushi Rupasinghe, Loveleen Bansi-Matharu, Matthew Law, et al.
The Lancet. HIV
|
April 15, 2024
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
Dathan M Byonanebye, Mark N Polizzotto, Fernando Maltez, et al.
Journal of Agricultural and Food Chemistry
|
November 1, 2016
Environmental Factors Correlated with the Metabolite Profile of Vitis vinifera cv. Pinot Noir Berry Skins along a European Latitudinal Gradient
María Ángeles Del-Castillo-Alonso, Antonella Castagna, Kristóf Csepregi, et al.
The Lancet. HIV
|
June 11, 2026
Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus
Tommaso Clemente, Arjen J Stam, Olof Elvstam, et al.
The Lancet. Infectious Diseases
|
October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
, , Dominique Costagliola, et al.
Antiviral Therapy
|
April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen
Daniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
The Lancet. HIV
|
June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study
Adam Trickey, Lei Zhang, M John Gill, et al.
Page
of 47
Search research articles
Search
Showing results (411-420 of 467) with videos related to
Sort By:
Page
of 47
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2025
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC)
Elise Pesonel, Cédric Laouénan, Laetitia Guiraud, et al.
Eclinicalmedicine
|
January 22, 2026
Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations
Win Min Han, Bastian Neesgaard, Michael Knappik, et al.
Lancet (London, England)
|
July 20, 2010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study
, Rebecca K Lodwick, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 8, 2024
Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium
Dhanushi Rupasinghe, Loveleen Bansi-Matharu, Matthew Law, et al.
The Lancet. HIV
|
April 15, 2024
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
Dathan M Byonanebye, Mark N Polizzotto, Fernando Maltez, et al.
Journal of Agricultural and Food Chemistry
|
November 1, 2016
Environmental Factors Correlated with the Metabolite Profile of Vitis vinifera cv. Pinot Noir Berry Skins along a European Latitudinal Gradient
María Ángeles Del-Castillo-Alonso, Antonella Castagna, Kristóf Csepregi, et al.
The Lancet. HIV
|
June 11, 2026
Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus
Tommaso Clemente, Arjen J Stam, Olof Elvstam, et al.
The Lancet. Infectious Diseases
|
October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study
, , Dominique Costagliola, et al.
Antiviral Therapy
|
April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen
Daniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
The Lancet. HIV
|
June 6, 2022
Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study
Adam Trickey, Lei Zhang, M John Gill, et al.
Page
of 47